BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20331975)

  • 1. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.
    Shen R; Pan S; Qi S; Lin X; Cheng S
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1047-52. PubMed ID: 20331975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
    Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
    Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
    Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG
    Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients.
    Yuan X; Wang S; Liu M; Lu Z; Zhan Y; Wang W; Xu AM
    Biomed Res Int; 2017; 2017():6894675. PubMed ID: 28133610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.
    Wang CY; Hua L; Sun J; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(11):14013-20. PubMed ID: 26823713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.
    Kang M; Li Y; Liu W; Wang R; Tang A; Hao H; Liu Z; Ou H
    Int J Mol Med; 2013 Jul; 32(1):51-8. PubMed ID: 23677061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4.
    Zou J; Xu Y
    Med Sci Monit; 2016 Jun; 22():2243-52. PubMed ID: 27353653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
    Feng L; Xie Y; Zhang H; Wu Y
    Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC.
    Chen X; Zhang L; Zhang T; Hao M; Zhang X; Zhang J; Xie Q; Wang Y; Guo M; Zhuang H; Lu F
    Liver Int; 2013 Mar; 33(3):476-86. PubMed ID: 23402613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
    Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
    Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibitory effects of three miR-129 family members on gastric cancer.
    Yu X; Song H; Xia T; Han S; Xiao B; Luo L; Xi Y; Guo J
    Gene; 2013 Dec; 532(1):87-93. PubMed ID: 24055727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA expression profile in undifferentiated gastric cancer.
    Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
    Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.
    Aaboe M; Birkenkamp-Demtroder K; Wiuf C; Sørensen FB; Thykjaer T; Sauter G; Jensen KM; Dyrskjøt L; Ørntoft T
    Cancer Res; 2006 Apr; 66(7):3434-42. PubMed ID: 16585165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
    Wu Q; Jin H; Yang Z; Luo G; Lu Y; Li K; Ren G; Su T; Pan Y; Feng B; Xue Z; Wang X; Fan D
    Biochem Biophys Res Commun; 2010 Feb; 392(3):340-5. PubMed ID: 20067763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
    Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y
    Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
    Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.